The ‘New (Nu)-clear’ evidence of the tumor-driving role of PI3K is a research paper published in Acta Materia Medica (2022). On theSindex it has a DataRank of 0.489. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.489
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R01 CA230453
NCI NIH HHS
Grant: P30 CA043703
National Institutes of Health
Grant: 3P30CA043703-20S1
Case Comprehensive Cancer Center Support Grant
National Institutes of Health
Grant: 5R01CA230453-05
Targeting DNA repair in KRAS mutated lung cancer by chemical screening
FWCI
1.96
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Chemodiversity, pharmacological activity, and biosynthesis of specialized metabolites from medicinal model fungi Ganoderma lucidum
Additional file 1 of Chemodiversity, pharmacological activity, and biosynthesis of specialized metabolites from medicinal model fungi Ganoderma lucidum